Why the study?
Does BQ123 attenuate ET-1-induced vasoconstriction in rat pulmonary artery rings and perfused lungs?
Does BQ123 attenuate ET-1-induced vasoconstriction in rat pulmonary artery rings and perfused lungs?
BQ123 effectively attenuates ET-1-induced vasoconstriction in rat pulmonary circulation, suggesting ETA receptors mediate this specific response.
Answers are grounded in this paper and cite their sources.
Supports ETA receptor role in rat pulmonary vasoconstriction; hypothesis-generating for human pulmonary hypertension therapy.
Endothelin-1 (ET-1) is a potent endogenous vasoactive peptide whose role in regulation of vascular tone is unclear. BQ123 is a recently described ETA receptor antagonist which may be useful in further investigation of the physiologic and pathophysiologic significance of ET-1. To test its efficacy in the pulmonary circulation, the vascular response to exogenous ET-1 with and without BQ123 was assessed in rat pulmonary artery (PA) rings and salt-perfused lungs. In both main and distal (250-350 microns ID) PA rings, BQ123 significantly attenuated ET-1-induced contractility, but was more effective in the larger vessels. Likewise, BQ123 significantly blunted ET-1-induced vasoconstriction in perfused lungs by > 80%. In addition, it had no effect on ET-3-mediated or U46619-mediated vasoconstriction, nor did it influence ET-1-induced vasodilation. Development of ET-1-associated hydrostatic edema was also unaffected by BQ123. We conclude that BQ123 effectively attenuates ET-1-induced vasoconstriction in both PA rings and in isolated perfused lungs. The absence of effect of BQ123 on ET-3 vasoconstriction, ET-1 vasodilation, or ET-1- and ET-3-induced hydrostatic edema formation suggests that these processes may be transduced through a non-ETA receptor.
No takes yet. Share an insight, caveat, or question.
Bonvallet et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: